Press Release
Select category
  • Select category
  • Aerospace & Defense
    • Aircraft Components
    • Aircraft Material
    • Aviation
    • Defense
    • Marine
    • Security
    • Space
    • Technology
  • Agriculture
    • Materials
    • Technology
  • Automotive
    • Automotive Systems
    • Chemical Automotive
    • Component
    • Freight & Logistics
    • Material
    • Technology
    • Transport Mode
    • Utility
    • Vehicle
  • Automotive (CI)
  • Baby Products and supplies
  • BFSI
    • Banking
  • Chemical and Materials
    • Advanced Materials
    • Chemical
    • Coatings and Additives
    • Composites
    • Paints
    • Textile
  • Chemical and Materials (CI)
  • Construction & Manufacturing
    • Agriculture
    • Construction and Improvements
    • Construction Materials
    • Decor
    • Equipment and Machinery
    • Industrial Equipment & Automation
    • Packaging
  • Construction & Manufacturing (CI)
  • Consumer & Goods
    • Baby products and supplies
    • Beauty & Personal Care
    • Consumer
    • Home Products
    • Retail
    • Sports & Fitness
    • Travel
  • Electronics and Semiconductor
    • Communication Equipment
    • Display Technology
    • Electronic Component
    • Electronic Devices
    • Emerging Technologies
    • Security
    • Semiconductor
    • Sensor & Control
    • Technology
  • Electronics and Semiconductor (CI)
  • Energy and Power
    • Conventional Energy
    • Equipment
    • Power
    • Renewable Energy
    • Services
    • Storage and Distribution
    • Technology
    • Utility
  • Energy and Power (CI)
  • Food & Beverage
    • Baby Food
    • Beverages
    • Dairy Products
    • Food Ingredient
    • Food Products
    • Food Services and Hospitality
    • Packaging
    • Processed Food
  • Healthcare
  • Healthcare (CI)
  • Industrial Automation & Equipment
    • Component
  • Information and Communication Technology
    • Communication
    • Data Center
    • Data Center and Networking
    • Emerging Technologies
    • Entertainment Technologies
    • Security
    • Software and Services
    • Technology
  • Information and Communication Technology ICT (CI)
  • Life Science
    • Biotechnology
    • Diagnostics and Biotech
    • Healthcare Equipment
    • Healthcare IT
    • Medical Devices
    • Packaging
    • Pharmaceutical
    • Therapeutic
  • Miscellaneous
    • BFSI
    • Education and Training
  • Uncategorized
Evolve Business Intelligence Evolve Business Intelligence
  • Home
  • About Us
  • Services
  • Market Reports
    • Automotive
      • Component
      • Vehicle
      • Chemical Automotive
      • Technology
      • Freight & Logistics
      • Material
      • Technology
      • Transport Mode
      • Utility
      • Vehicle
    • Chemical and Materials
      • Chemical
      • Advanced Materials
      • Coatings and Additives
      • Composites
      • Paints
      • Textile
    • Aerospace & Defense
      • Marine
      • Security
      • Technology
      • Aircraft Components
      • Aircraft Material
    • Construction & Manufacturing
    • Electronics and Semiconductor
      • Display Technology
      • Electronic Component
      • Electronic Devices
      • Semiconductor
      • Communication Equipment
      • Emerging Technologies
      • Security
      • Sensor & Control
      • Technology
    • Energy and Power
    • Life Science
    • Consumer & Goods
      • Baby products and supplies
      • Beauty & Personal Care
      • Consumer
      • Home Products
    • Information and Communication Technology
      • Emerging Technologies
      • Entertainment Technologies
      • Security
      • Communication
      • Data Center
      • Data Center and Networking
      • Software and Services
      • Technology
  • Competitive Intelligence (CI)
    • Automotive (CI)
    • Chemical and Materials (CI)
    • Construction & Manufacturing (CI)
    • Energy and Power (CI)
    • Electronics and Semiconductor (CI)
    • Healthcare (CI)
    • Information and Communication Technology ICT (CI)
  • Contact Us
Menu
Evolve Business Intelligence Evolve Business Intelligence
Press Release
Life Science
Click to enlarge
Home » Our Report Repository » Remdesivir (COVID 19) Market Analysis and Forecast (2021-2028) with COVID Impact Analysis
Combat Management System Market Analysis and Forecast (2021-2028) with COVID Impact Analysis $4,745.60(Approx. $ 3,475.00)
Back to products
Life Science
Formulation Development Outsourcing Market Analysis and Forecast (2021-2028) with COVID Impact Analysis $4,745.60(Approx. $ 3,475.00)

Remdesivir (COVID 19) Market Analysis and Forecast (2021-2028) with COVID Impact Analysis

$4,745.60(Approx. $ 3,475.00)

Remdesivir (COVID 19) Market by Dosage Type (5mg, 10 mg, 100mg), By Distribution Channel (Hospitals, Drug stores, Others) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028

Report Code: EB_LS_1081| Page: 106 | Published Date: June 2021

Categories: Life Science, Pharmaceutical
Share:
  • Description
  • Table of Content
  • Connect to Analyst
  • Research Methodology
Description

The global Remdesivir (COVID 19) market size is expected to grow at a CAGR of 45.26% from 2021 to 2028. This growth is attributed to several macro and micro economic factors such as

  • Rise in frequency of Covid-19 are the driving factor for Remdesivir (COVID 19)
  • Driver 2

Further several factors restraining the market growth include

  • Restraining 1
  • Restraining 2

Collaborations and Alliances in the Remdesivir (COVID 19) market is expected to generate higher avenues during the forecast period.

The COVID-19 pandemic has led to supply chain disruptions leading to supply shortages or lower demand in the Remdesivir (COVID 19) market. The travel restrictions and social-distancing measures have resulted in a sharp drop in consumer and business spending and this pattern is to continue for some time. The end-user trend and preferences have changed due to the pandemic and have resulted in manufacturers, developers, and service providers to adopt various strategies to stabilize the company.

 In terms of COVID 19 impact, the Remdesivir (COVID 19) market report also includes following data points:

  • Impact on Remdesivir (COVID 19) market size
  • End User Trend, Preferences and Budget Impact
  • Regulatory Framework/Government Policies
  • Key Players Strategy to Tackle Negative Impact/Post-COVID Strategies
  • Opportunity in Remdesivir (COVID 19) market

 

Key Insight in the report:

The global Remdesivir (COVID 19) market report covers executive summary, market dynamics, COVID impact & post COVID scenario, market size and forecast, competitive intelligence, market positioning, and product offerings.

Our report covers extensive competitive intelligence which include following data points:

  • Business Overview
  • Business Segment Data
  • Financial Data
  • Dosage Segment Analysis and Specification
  • Recent Development and Company Strategy Analysis
  • SWOT Analysis

The report covers market sizing and forecasting at the country level as well as at the segment level. Remdesivir (COVID 19) market is analyzed across below-mentioned different segments:

  • Dosage Type
    • 5mg
    • 10 mg
    • 100mg
  • Distribution Channel
    • Hospitals
    • Drug stores
    • Others

Remdesivir (COVID 19) market is also analyzed across below-mentioned regions/countries:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest of Asia Pacific
  • Rest of the World
    • South America
    • Middle East & Africa

Some of the key players in Remdesivir (COVID 19) market include:

  • Gilead Sciences, Inc.
  • Mylan
  • Cipla
  • Hetero Labs
  • Bright Gene
  • Hainan Haiyao
  • Kelun Pharma
  • Hunan Warrant Pharmaceutical
  • Borui Bio-Pharmaceutical
  • Jubilant Life Sciences

REPORT CONTENT BRIEF:

  • High level analysis of the current and future market trends and opportunities
  • Detailed analysis on current market drivers, restraining factors, and opportunities in the future
  • Remdesivir (COVID 19) market estimates for 2021 and forecast from 2022 to 2028 with CAGR from 2021 to 2028.
  • Vendor market share analysis at each product level
  • Competitor analysis with a detailed insight into its product segment, financial strength, and strategies adopted.
  • Identifies key strategies adopted including product launches and developments, mergers and acquisitions, joint ventures, collaborations and partnerships as well as funding taken and investment done, among others.

Target Audience

  • Manufacturers
  • Suppliers and traders
  • Government, associations, and industrial bodies
  • Investors and trade experts
  • Consulting Firms or Individual Consultant
  • Anyone interested in understanding industry dynamic of Remdesivir (COVID 19) market

For more details mail us at

[email protected]

Ask a question / additional requirement

Press Release

  • The Global Double Chamber Injection Devices Market Is Estimated To Record a CAGR of Around 9.99% During The Forecast Period

    The Global Double Chamber Injection Devices Market Is Estimated To Record a CAGR of Around 9.99% During The Forecast Period

    August 26, 2023

  • The Global Flexible Printed Circuit Board Market Is Estimated To Record a CAGR of Around 11.60% During The Forecast Period

    The Global Flexible Printed Circuit Board Market Is Estimated To Record a CAGR of Around 11.60% During The Forecast Period

    August 26, 2023

  • The Global Clinical Biomarkers Market Is Estimated To Record a CAGR of Around 16.7% During The Forecast Period

    The Global Clinical Biomarkers Market Is Estimated To Record a CAGR of Around 16.7% During The Forecast Period

    August 26, 2023

  • The Global Data Center Environmental Monitoring System Market Is Estimated To Record a CAGR of Around 8.45% During The Forecast Period

    The Global Data Center Environmental Monitoring System Market Is Estimated To Record a CAGR of Around 8.45% During The Forecast Period

    August 26, 2023

  • The Global Data Center Networking Market Is Estimated To Record a CAGR of Around 15.55% During The Forecast Period

    The Global Data Center Networking Market Is Estimated To Record a CAGR of Around 15.55% During The Forecast Period

    August 26, 2023

  • The Global Graft Delivery Device Market Is Estimated To Record a CAGR of Around 12.99% During The Forecast Period

    The Global Graft Delivery Device Market Is Estimated To Record a CAGR of Around 12.99% During The Forecast Period

    August 26, 2023

  • The Global HubSpot Consulting and Implementation Market Is Estimated To Record a CAGR of Around 15.23% During The Forecast Period

    The Global HubSpot Consulting and Implementation Market Is Estimated To Record a CAGR of Around 15.23% During The Forecast Period

    August 26, 2023

  • The Global Liquid Skin Protectors Market Is Estimated To Record a CAGR of Around 10.64% During The Forecast Period

    The Global Liquid Skin Protectors Market Is Estimated To Record a CAGR of Around 10.64% During The Forecast Period

    August 26, 2023

  • The Global Lithium-Ion Battery Energy Storage System Market Is Estimated To Record a CAGR of Around 15.5% During The Forecast Period

    The Global Lithium-Ion Battery Energy Storage System Market Is Estimated To Record a CAGR of Around 15.5% During The Forecast Period

    August 26, 2023

  • The Global Machine Safety Market Is Estimated To Record a CAGR of Around 6.9% During The Forecast Period

    The Global Machine Safety Market Is Estimated To Record a CAGR of Around 6.9% During The Forecast Period

    August 26, 2023

Table of Content

Table of Content

Chapter 1.   Executive Summary

Chapter 2.   Scope of The Study

                     2.1.   Market Definition

                     2.2.   Scope of The Study

                               2.2.1.   Objectives of Report

Chapter 3.   Evolve BI Methodology

Chapter 4.   Market Insights and Trends

                     4.1.   Supply/ Value Chain Analysis

                     4.2.   Porter’s Five Forces Analysis

                               4.2.1.   Threat of New Entrants

                               4.2.2.   Bargaining Power of Buyers

                               4.2.3.   Bargaining Power of Suppliers

                               4.2.4.   Threat of Substitutes

                               4.2.5.   Industry Rivalry

                     4.3.   Impact of COVID-19 on Remdesivir (COVID 19) Market

                               4.3.1.   Impact on Market Size

                               4.3.2.   End User Trend, Preferences and Budget Impact

                               4.3.3.   Regulatory Framework/Government Policies

                               4.3.4.   Key Players Strategy to Tackle Negative Impact

                               4.3.5.   Opportunity Window

Chapter 5.   Market Dynamics

                     5.1.   Introduction

                     5.2.   DRO Analysis

                               5.2.1.   Drivers

                               5.2.2.   Restraints

                               5.2.3.   Opportunities

Chapter 6.   Global Remdesivir (COVID 19) Market, By Dosage Type

                     6.1.   Introduction

                     6.2.   5mg

                     6.3.   10 mg

                     6.4.   100mg

Chapter 7.   Global Remdesivir (COVID 19) Market, By Distribution Channel

                     7.1.   Introduction

                     7.2.   Hospitals

                     7.3.   Drug stores

                     7.4.   Others

Chapter 8.   Global Remdesivir (COVID 19) Market, By Region

                     8.1.   Introduction

                     8.2.   North America

                               8.2.1.   Introduction

                               8.2.2.   Driving Factors, Opportunity Analyzed and Key Trends

                               8.2.3.   Market Size and Forecast, By Country, 2020 - 2028

                               8.2.4.   Market Size and Forecast, By Dosage Type, 2020 - 2028

                               8.2.5.   Market Size and Forecast, By Distribution Channel, 2020 – 2026

                               8.2.6.   US

                                              8.2.6.1.   Introduction

                                              8.2.6.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              8.2.6.3.   Market Size and Forecast, By Dosage Type, 2020 - 2028

                                              8.2.6.4.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                               8.2.7.   Canada

                                              8.2.7.1.   Introduction

                                              8.2.7.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              8.2.7.3.   Market Size and Forecast, By Dosage Type, 2020 - 2028

                                              8.2.7.4.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                     8.3.   Europe

                               8.3.1.   Introduction

                               8.3.2.   Driving Factors, Opportunity Analyzed and Key Trends

                               8.3.3.   Market Size and Forecast, By Country, 2020 - 2028

                               8.3.4.   Market Size and Forecast, By Dosage Type, 2020 - 2028

                               8.3.5.   Market Size and Forecast, By Distribution Channel, 2020 – 2026

                               8.3.6.   Germany

                                              8.3.6.1.   Introduction

                                              8.3.6.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              8.3.6.3.   Market Size and Forecast, By Dosage Type, 2020 - 2028

                                              8.3.6.4.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                               8.3.7.   France

                                              8.3.7.1.   Introduction

                                              8.3.7.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              8.3.7.3.   Market Size and Forecast, By Dosage Type, 2020 - 2028

                                              8.3.7.4.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                               8.3.8.   UK

                                              8.3.8.1.   Introduction

                                              8.3.8.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              8.3.8.3.   Market Size and Forecast, By Dosage Type, 2020 - 2028

                                              8.3.8.4.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                               8.3.9.   Italy

                                              8.3.9.1.   Introduction

                                              8.3.9.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              8.3.9.3.   Market Size and Forecast, By Dosage Type, 2020 - 2028

                                              8.3.9.4.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                               8.3.10.   Rest of Europe

                                              8.3.10.1.   Introduction

                                              8.3.10.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              8.3.10.3.   Market Size and Forecast, By Dosage Type, 2020 - 2028

                                              8.3.10.4.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                     8.4.   Asia-Pacific

                               8.4.1.   Introduction

                               8.4.2.   Driving Factors, Opportunity Analyzed and Key Trends

                               8.4.3.   Market Size and Forecast, By Country, 2020 - 2028

                               8.4.4.   Market Size and Forecast, By Dosage Type, 2020 - 2028

                               8.4.5.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                               8.4.6.   China

                                              8.4.6.1.   Introduction

                                              8.4.6.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              8.4.6.3.   Market Size and Forecast, By Dosage Type, 2020 - 2028

                                              8.4.6.4.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                               8.4.7.   India

                                              8.4.7.1.   Introduction

                                              8.4.7.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              8.4.7.3.   Market Size and Forecast, By Dosage Type, 2020 - 2028

                                              8.4.7.4.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                               8.4.8.   Japan

                                              8.4.8.1.   Introduction

                                              8.4.8.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              8.4.8.3.   Market Size and Forecast, By Dosage Type, 2020 - 2028

                                              8.4.8.4.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                               8.4.9.   South Korea

                                              8.4.9.1.   Introduction

                                              8.4.9.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              8.4.9.3.   Market Size and Forecast, By Dosage Type, 2020 - 2028

                                              8.4.9.4.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                               8.4.10.   Rest of Asia-Pacific

                                              8.4.10.1.   Introduction

                                              8.4.10.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              8.4.10.3.   Market Size and Forecast, By Dosage Type, 2020 - 2028

                                              8.4.10.4.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                     8.5.   Rest of The World (RoW)

                               8.5.1.   Introduction

                               8.5.2.   Driving Factors, Opportunity Analyzed and Key Trends

                               8.5.3.   Market Size and Forecast, By Dosage Type, 2020 - 2028

                               8.5.4.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                               8.5.5.   Market Size and Forecast, By Region, 2020 - 2028

                               8.5.6.   South America

                                              8.5.6.1.   Introduction

                                              8.5.6.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              8.5.6.3.   Market Size and Forecast, By Dosage Type, 2020 - 2028

                                              8.5.6.4.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

                               8.5.7.   Middle East and Africa

                                              8.5.7.1.   Introduction

                                              8.5.7.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              8.5.7.3.   Market Size and Forecast, By Dosage Type, 2020 - 2028

                                              8.5.7.4.   Market Size and Forecast, By Distribution Channel, 2020 - 2028

Chapter 9.   Competitive Landscape

                     9.1.   Introduction

                     9.2.   Vendor Share Analysis, 2020/Key Players Positioning, 2020

Chapter 10.   Company Profiles

                     10.1.   Gilead Sciences, Inc.

                               10.1.1.   Business Overview

                               10.1.2.   Financial Analysis

                               10.1.3.   Dosage Portfolio

                               10.1.4.   Recent Development and Strategies Adopted

                               10.1.5.   SWOT Analysis

                     10.2.   Mylan

                               10.2.1.   Business Overview

                               10.2.2.   Financial Analysis

                               10.2.3.   Dosage Portfolio

                               10.2.4.   Recent Development and Strategies Adopted

                               10.2.5.   SWOT Analysis

                     10.3.   Cipla

                               10.3.1.   Business Overview

                               10.3.2.   Financial Analysis

                               10.3.3.   Dosage Portfolio

                               10.3.4.   Recent Development and Strategies Adopted

                               10.3.5.   SWOT Analysis

                     10.4.  Hetero Labs

                               10.4.1.   Business Overview

                               10.4.2.   Financial Analysis

                               10.4.3.   Dosage Portfolio

                               10.4.4.   Recent Development and Strategies Adopted

                               10.4.5.   SWOT Analysis

                     10.5.   Bright Gene

                               10.5.1.   Business Overview

                               10.5.2.   Financial Analysis

                               10.5.3.   Dosage Portfolio

                               10.5.4.   Recent Development and Strategies Adopted

                               10.5.5.   SWOT Analysis

                     10.6.   Hainan Haiyao

                               10.6.1.   Business Overview

                               10.6.2.   Financial Analysis

                               10.6.3.   Dosage Portfolio

                               10.6.4.   Recent Development and Strategies Adopted

                               10.6.5.   SWOT Analysis

                     10.7.   Kelun Pharma

                               10.7.1.   Business Overview

                               10.7.2.   Financial Analysis

                               10.7.3.   Dosage Portfolio

                               10.7.4.   Recent Development and Strategies Adopted

                               10.7.5.   SWOT Analysis

                     10.8.   Hunan Warrant Pharmaceutical

                               10.8.1.   Business Overview

                               10.8.2.   Financial Analysis

                               10.8.3.   Dosage Portfolio

                               10.8.4.   Recent Development and Strategies Adopted

                               10.8.5.   SWOT Analysis

                     10.9.   Borui Bio-Pharmaceutical

                               10.9.1.   Business Overview

                               10.9.2.   Financial Analysis

                               10.9.3.   Dosage Portfolio

                               10.9.4.   Recent Development and Strategies Adopted

                               10.9.5.   SWOT Analysis

                     10.10.   Jubilant Life Sciences

                               10.10.1.   Business Overview

                               10.10.2.   Financial Analysis

                               10.10.3.   Dosage Portfolio

                               10.10.4.   Recent Development and Strategies Adopted

                               10.10.5.   SWOT Analysis

 

Chapter 11.   Key Takeaways

Connect to Analyst

Connect to Analyst

Research Methodology

Research Methodology

Related products

Life Science

Track and Trace Solutions Market Analysis and Global Forecast (2021-2028) with COVID Impact Analysis

$4,745.60(Approx. $ 3,475.00)
Track and Trace Solutions Market By Product Type (Hardware Components, Software, Standalone Platforms, Tracking, Tracing and Reporting Solutions), By Application (Serialization Solutions, Medical Devices Serialization Aggregation Solution) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028 Report Code: EB_LS_332| Page: 163| Published Date: March 2021
Add to cart
Quick view
Healthcare

Global Telehealth Market

$4,745.60(Approx. $ 3,475.00)
Telehealth Market By Component (Hardware, Software, Service) By Delivery Mode (Web-based, Cloud-based, On-Premise) By End User (Provider, Payer, Patient, Others) and By Geography: Global trends, opportunities and forecast – 2020 to 2027
Add to cart
Quick view
Life Science

Proteinase K Market Analysis and Global Forecast (2020-2027) with COVID Impact Analysis

$4,745.60(Approx. $ 3,475.00)
Proteinase K Market By Type (Natural, Recombinant), Form Factor (Liquid, Powder, Tablet), End User (Bio-Pharmaceutical, Pharmaceutical, Academic and Research Centers, Hospitals, Contract Research Organization, Diagnostic Laboratories) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2020 to 2027 Report Code: EB_LS_451 | Page: 124| Published Date: March 2021
Add to cart
Quick view
Life Science

India Blood Product Market Analysis and Global Forecast (2021-2027) with COVID Impact Analysis

$4,745.60(Approx. $ 3,475.00)

Blood Product Market by Type (Coagulation Factor, Immune Globulin, Albumin), By Application (Surgery, Therapy, Immunity) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2007

Report Code: EB_LS_463| Page: 77 | Published Date: July 2021
Add to cart
Quick view
Life Science

Gene Therapy Cell Culture Media Market Analysis and Forecast (2021-2028) with COVID Impact Analysis

$4,745.60(Approx. $ 3,475.00)

Gene Therapy Cell Culture Media Market By Product Type (Media, Viral Vectors), By Application (Biotechnology & Pharmaceutical Industry, Research Laboratory, Academic Institute, Others) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028

Report Code: EB_LS_333| Page: 164 | Published Date: May 2021
Add to cart
Quick view
Life Science

Cannabis Extraction Market Analysis and Global Forecast (2021-2027) with COVID Impact Analysis

$4,745.60(Approx. $ 3,475.00)

Cannabis Extraction Market By Type (Dry-Sieve Extraction, Water Extraction, Rosin Press Extraction, Isopropyl Oil or Quick-Wash ISO Extraction), By Application (Food, Medicine, Cosmetics, Others) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2027

Report Code: EB_LS_443 | Page: 93 | Published Date: June 2021
Add to cart
Quick view
Life Science

Particle Counters Market Analysis and Global Forecast (2020-2028) with COVID Impact Analysis

$4,745.60(Approx. $ 3,475.00)
Particle Counters Market By Product Type (Cleanroom Monitoring, Drinking Water Contamination Monitoring, Aerosol Monitoring and Research, Others), By Type (Airborne Particle Counters, Liquid Particle Counters) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028 Report Code: EB_LS_338| Page: 169 | Published Date : March 2021
Add to cart
Quick view
Life Science

Oncology information systems Market Analysis and Global Forecast (2020-2028) with COVID Impact Analysis

$4,745.60(Approx. $ 3,475.00)
Oncology information systems Market By Application (Radiation Oncology, Medical Oncology, Surgical Oncology, ), By Product (Software, Services) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028 Report Code: EB_LS_335| Page: 167 | Published Date: March 2021
Add to cart
Quick view

Uncover Market Secrets: Get Market Insights in Your Inbox 🚀

Join over 5,000 professionals staying ahead of industry trends. Subscribe to our weekly market research newsletter.

Join our community of industry leaders and stay ahead of the curve. Subscribe now for data-driven market intelligence and strategic recommendations that will set your business on a path to success! Don't miss out on our FREE exclusive insights – sign up today and soar above your competition!🚀

cropped-evolvebi-Logo-2021-1.png
M/S Evolve Business Intelligence C-218, 2nd floor, M-Cube, N.H. – 48, Balitha, Vapi, Valsad- Gujarat
Email: [email protected]

Email: [email protected]

  • Important Links
    • About Evolvebi
    • Competitive Intelligence
    • Become a reseller
    • Contact Us
  • Top Search By Countries Hot
    • United State
    • Europe
    • Asia Pacific
    • Middle East & Africa
    • Latin America

© 2021 - 2023 Evolve Business Intelligence. All rights reserved. Developed by Nectron

Privacy Policy | Terms and Conditions | Cancellation and Refund policy

  • Home
  • About Us
  • Services
  • Market Reports
    • Automotive
      • Component
      • Vehicle
      • Chemical Automotive
      • Technology
      • Freight & Logistics
      • Material
      • Technology
      • Transport Mode
      • Utility
      • Vehicle
    • Chemical and Materials
      • Chemical
      • Advanced Materials
      • Coatings and Additives
      • Composites
      • Paints
      • Textile
    • Aerospace & Defense
      • Marine
      • Security
      • Technology
      • Aircraft Components
      • Aircraft Material
    • Construction & Manufacturing
    • Electronics and Semiconductor
      • Display Technology
      • Electronic Component
      • Electronic Devices
      • Semiconductor
      • Communication Equipment
      • Emerging Technologies
      • Security
      • Sensor & Control
      • Technology
    • Energy and Power
    • Life Science
    • Consumer & Goods
      • Baby products and supplies
      • Beauty & Personal Care
      • Consumer
      • Home Products
    • Information and Communication Technology
      • Emerging Technologies
      • Entertainment Technologies
      • Security
      • Communication
      • Data Center
      • Data Center and Networking
      • Software and Services
      • Technology
  • Competitive Intelligence (CI)
    • Automotive (CI)
    • Chemical and Materials (CI)
    • Construction & Manufacturing (CI)
    • Energy and Power (CI)
    • Electronics and Semiconductor (CI)
    • Healthcare (CI)
    • Information and Communication Technology ICT (CI)
  • Contact Us
We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.
More info Accept
I allow the Site owner to contact me via email/phone to discuss this enquiry. (If you want to know more about the way this site handles the data, then please go through our privacy policy).
Brought to you by WisdmLabs: WordPress Development Experts

Sending...